GSK hires at Sligo facility; Apotex recalls nearly 92,000 bottles of Losartan;

> GlaxoSmithKline intends ($GSK) to add 50 employees to its consumer plant in Sligo, Ireland. Report

> U.K.-based CMO Quantum Pharma has expanded its manufacturing capabilities with the £9.34 million ($14.57 million) acquisition of NuPharm Group. Report

> Canadian drugmaker Apotex is recalling about 92,000 bottles of the hypertension drug Losartan saying it may not meet the limit for blend uniformity specification. Notice

Suggested Articles

Recipharm has been building its capabilities in sterile injectable and inhalation drugs. Now it is buying a CDMO that manufactures devices for both.

The FDA has slapped the parent of Dollar Tree stores with a warning letter saying some CMOs that made its OTC products were among the world's worst.

GSK expects Shingrix supplies to rise slightly in 2020, but the real "step change" will come in 2024 with a brand-new manufacturing facility.